- Home
- CEE vs OSTX Comparison
CEE vs OSTX Comparison
Compare CEE & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEE
- OSTX
- Stock Information
- Founded
- CEE 1990
- OSTX 2018
- Country
- CEE Germany
- OSTX United States
- Employees
- CEE N/A
- OSTX N/A
- Industry
- CEE Finance Companies
- OSTX
- Sector
- CEE Finance
- OSTX
- Exchange
- CEE Nasdaq
- OSTX NYSE
- Market Cap
- CEE 79.2M
- OSTX 86.5M
- IPO Year
- CEE N/A
- OSTX 2024
- Fundamental
- Price
- CEE $11.97
- OSTX $3.81
- Analyst Decision
- CEE
- OSTX Strong Buy
- Analyst Count
- CEE 0
- OSTX 2
- Target Price
- CEE N/A
- OSTX $14.50
- AVG Volume (30 Days)
- CEE 22.0K
- OSTX 110.3K
- Earning Date
- CEE 01-01-0001
- OSTX 02-15-2025
- Dividend Yield
- CEE 3.86%
- OSTX N/A
- EPS Growth
- CEE N/A
- OSTX N/A
- EPS
- CEE N/A
- OSTX N/A
- Revenue
- CEE N/A
- OSTX N/A
- Revenue This Year
- CEE N/A
- OSTX N/A
- Revenue Next Year
- CEE N/A
- OSTX $9,900.00
- P/E Ratio
- CEE N/A
- OSTX N/A
- Revenue Growth
- CEE N/A
- OSTX N/A
- 52 Week Low
- CEE $7.80
- OSTX $1.58
- 52 Week High
- CEE $10.32
- OSTX $6.48
- Technical
- Relative Strength Index (RSI)
- CEE 53.41
- OSTX N/A
- Support Level
- CEE $11.16
- OSTX N/A
- Resistance Level
- CEE $12.26
- OSTX N/A
- Average True Range (ATR)
- CEE 0.44
- OSTX 0.00
- MACD
- CEE -0.07
- OSTX 0.00
- Stochastic Oscillator
- CEE 60.45
- OSTX 0.00
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.